Drugs / EDK060
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07140614 | Sep 2025 → Feb 2028 expected | Charcot-Marie-Tooth disease type 1A | Novartis Pharmaceuticals | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EDK060 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07140614 ↗ |
| Route | Intravenous | “IV infusion” NCT07140614 ↗ |